Feasibility Trial of a Staged Epicardial & Endocardial Approach for Treatment of Patients With Persistent or Long Standing Persistent Atrial Fibrillation With Radiofrequency Ablation

The purpose of this study is to assess the safety and technical feasibility of treating subjects with Persistent Atrial Fibrillation or Longstanding Persistent Atrial Fibrillation in a minimally invasive thoracoscopic ablation procedure utilizing the AtriCure Bipolar System, with mapping and additional lesion creation/ gap closure (as needed) provided by currently approved catheter technology, when the epicardial and endocardial phases are performed in a staged manner within 1-10 days apart, during the same hospitalization.

Stanford is now accepting new patients for this trial. Please contact Linda Norton at 650-725-5597 for more information.

Investigator(s):

Intervention(s):

  • device : Ablation procedure staged catheter ablation

Phase: Phase 1/Phase 2

Eligibility

Ages Eligible For Study:

18 Years - N/A

Inclusion Criteria

- Age > 18 year - Patients with symptomatic persistent or longstanding persistent AF refractory to a minimum of one Class I or III AAD(s). - Patients with failed catheter ablation attempts are eligible if the patients are symptomatic with persistent or longstanding persistent AF. (catheter ablation procedure must be more than 3 months prior to index procedure) - Life expectancy of at least two years - Patient will and able to provide informed consent - Patient is willing and able to attend the scheduled follow-up visits

External Links

Explore related trials

Contact information

Primary Contact:

Linda Norton 650-725-5597

Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305

Stanford Medicine Resources:

Footer Links: